SKU: OPC-NINTABID-150-CAP
Nintabid 150mg Capsule contains Nintedanib 150mg and is a prescription antifibrotic medicine used under medical supervision for selected progressive fibrosing lung conditions.
Nintabid 150mg Capsule contains Nintedanib 150mg, an antifibrotic medicine used under specialist medical supervision for selected chronic lung conditions associated with progressive scarring. Nintedanib works on specific signalling pathways involved in abnormal tissue growth and fibrosis, helping slow the progression of certain fibrosing lung diseases.
Progressive lung fibrosis can cause lung tissue to become increasingly scarred and stiff, which may gradually affect breathing and lung function. Nintabid 150mg is designed to help slow this disease process rather than provide an immediate cure. Treatment should be started and monitored by a qualified healthcare professional.
Nintabid 150mg belongs to a class of medicines known as tyrosine kinase inhibitors. It acts on several growth-factor pathways involved in the development and progression of fibrosis. Because this medicine can affect the liver and may cause other clinically important effects, regular medical monitoring is important during treatment.
For more products related to respiratory wellness, explore our Respiratory Care collection.
For additional information about lung health and respiratory conditions, visit the American Lung Association.
Nintabid 150mg Capsule is an oral medicine containing Nintedanib 150mg. It is used for specific chronic lung conditions in adults. Nintedanib is an antifibrotic agent that targets pathways involved in the development of abnormal fibrosis.
The medicine is primarily associated with treatment of idiopathic pulmonary fibrosis and may also be prescribed for other appropriate progressive fibrosing interstitial lung diseases according to the clinical indication and prescribing guidance.
Nintabid 150mg is a prescription medicine and should not be started, stopped or adjusted without medical advice. The exact treatment plan depends on the patient's diagnosis, overall health, tolerance and response to therapy.
Nintedanib is used in the management of idiopathic pulmonary fibrosis, a chronic lung condition in which scar tissue progressively develops within the lungs. Nintabid may help slow the decline in lung function associated with disease progression.
Nintedanib may be prescribed for selected chronic fibrosing interstitial lung diseases that show a progressive phenotype. The decision to use treatment depends on the specific diagnosis and assessment by a specialist.
Nintedanib may be used in additional approved clinical situations depending on the patient's diagnosis and applicable prescribing guidance. It should only be used for the indication determined by a qualified healthcare professional.
For educational resources about pulmonary fibrosis, visit the Pulmonary Fibrosis Foundation.
Nintabid targets signalling pathways involved in fibrotic activity. By interfering with these pathways, Nintedanib can help slow the progression of certain fibrosing lung diseases.
Progressive fibrosis can gradually reduce lung function. By slowing the rate of disease progression, Nintedanib may help preserve respiratory function for longer in appropriate patients.
Nintedanib acts on several receptor tyrosine kinases involved in pathways associated with fibrosis and abnormal cellular activity. This multi-pathway action is an important part of its antifibrotic effect.
Fibrosing lung diseases often require long-term medical management. Nintabid can form part of a specialist-directed treatment plan intended to slow disease progression and maintain respiratory health.
Each Nintabid 150mg soft gelatin capsule contains:
Nintedanib is an antifibrotic medicine that inhibits multiple receptor tyrosine kinases involved in signalling pathways associated with fibrosis and abnormal tissue growth.
These pathways can contribute to the development and progression of fibrotic changes in the lungs. By blocking relevant signalling activity, Nintedanib helps reduce processes that contribute to progressive scarring.
Nintabid does not remove existing scar tissue from the lungs and is not considered a cure for pulmonary fibrosis. Its main therapeutic purpose is to slow the progression of appropriate fibrosing lung disease.
Idiopathic pulmonary fibrosis is a chronic condition in which lung tissue becomes progressively scarred. As fibrosis advances, the lungs may become less flexible and breathing can become increasingly difficult.
Nintedanib is used to slow the decline in lung function associated with IPF. Treatment is generally long term and requires ongoing assessment by the treating healthcare professional.
The medicine should be used exactly as prescribed, with regular follow-up appointments and appropriate monitoring.
Take Nintabid 150mg exactly as prescribed by your doctor. The capsule should generally be taken with food and swallowed whole with water.
Do not crush, chew or open the soft gelatin capsule unless your healthcare professional specifically instructs you to do so. Try to take the medicine at consistent times each day.
The prescribed dose may vary depending on the clinical indication, tolerability and individual circumstances. Your doctor may adjust the treatment if side effects occur or if your medical condition requires a change in therapy.
The recommended dosage of Nintedanib depends on the condition being treated and the patient's ability to tolerate the medicine. For some adult indications, Nintedanib may be prescribed at 150mg twice daily, but the exact dose must be determined by the treating physician.
Do not change the dose yourself. Your doctor may temporarily interrupt treatment or reduce the dose if clinically significant side effects occur.
Common side effects associated with Nintedanib may include diarrhoea, nausea, vomiting, abdominal pain, decreased appetite, weight loss and headache. Changes in liver enzymes may also occur during treatment.
Diarrhoea can sometimes become significant and may lead to dehydration. Contact your doctor if symptoms are persistent, severe or difficult to control.
Seek prompt medical attention if you experience symptoms that could indicate serious liver problems, severe bleeding, significant abdominal pain or another serious reaction.
Nintabid 150mg is generally taken with food. Taking it with food may also help improve gastrointestinal tolerability.
Follow your doctor's instructions regarding timing and food intake, and take the capsule consistently according to your prescribed schedule.
Nintedanib can affect liver enzymes, making liver-function monitoring an important part of treatment. Your doctor may order blood tests before treatment and at intervals during therapy.
Tell your doctor about any history of liver disease and report symptoms such as unusual tiredness, loss of appetite, dark urine, yellowing of the skin or eyes, or other unusual changes.
Nintedanib may cause harm to an unborn baby. If you are pregnant, planning pregnancy or think you may be pregnant, inform your doctor before taking Nintabid.
Women who can become pregnant should discuss effective contraception with their healthcare professional during treatment and for the recommended period after treatment.
Tell your doctor if you are breastfeeding or planning to breastfeed. Your healthcare professional will determine whether Nintabid is appropriate and discuss the safest treatment approach.
Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and supplements you use. Some medicines can affect Nintedanib exposure or increase the risk of adverse effects.
Medicines that influence bleeding risk should be discussed with your doctor before starting Nintabid. Do not start or stop another medicine without professional advice.
If you miss a dose of Nintabid, follow the instructions provided by your doctor or pharmacist. Do not take an extra dose to make up for a missed dose.
If you are unsure what to do after missing a dose, contact your healthcare professional for individualized advice.
Diarrhoea is one of the commonly reported side effects of Nintedanib. Persistent diarrhoea can cause dehydration and may require medical management.
Maintain adequate fluid intake and follow your doctor's instructions if diarrhoea occurs. If symptoms are severe or do not improve, contact your healthcare professional promptly.
Decreased appetite and weight loss can occur during Nintedanib treatment. Maintaining adequate nutrition is important, particularly in people who are already underweight or have chronic lung disease.
Discuss unexplained or significant weight loss with your healthcare professional so that the cause can be evaluated and appropriate nutritional support can be considered.
Nintabid 150mg Capsule is a prescription medicine containing Nintedanib 150mg. It is an antifibrotic medicine used for selected chronic fibrosing lung conditions.
Nintabid is primarily used to slow the progression of idiopathic pulmonary fibrosis and may be used for other appropriate progressive fibrosing interstitial lung diseases under specialist guidance.
Nintabid 150mg contains Nintedanib 150mg.
Nintabid works by inhibiting multiple signalling pathways involved in fibrotic activity and abnormal tissue growth, helping slow the progression of certain fibrosing lung diseases.
Yes, Nintedanib is generally taken with food. Follow the exact instructions provided by your treating doctor.
Do not stop Nintabid without speaking to your doctor. Treatment decisions should be made according to your condition, response and tolerability.
Commonly reported effects include diarrhoea, nausea, vomiting, abdominal pain, decreased appetite, weight loss and headache.
Nintabid does not cure established pulmonary fibrosis or remove existing scar tissue. Its purpose is to slow disease progression in appropriate patients.
Yes. Nintabid 150mg is a prescription medicine and should be used under the supervision of a qualified healthcare professional.
This information is provided for general educational purposes and does not replace professional medical advice, diagnosis or treatment. Nintabid 150mg Capsule is a prescription medicine and should be taken only according to the instructions of a qualified healthcare professional.
Individual treatment requirements vary. Always follow your doctor's instructions regarding dosage, monitoring, duration of treatment and management of side effects.
| Brand | Nintabid |
| Manufacturer | Pharmaceuticals Ltd. |
| Composition | Nintedanib 150mg |
| Package | 10 Capsules |
| Ship time | 5-10 Business Days |
Free Shipping
For all oders over $99
Secure Payment
100% secure payment
24/7 Support
Online top support